These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6315599)

  • 1. Stability of the radiopharmaceutical [99mTc]DMSA: study of the ligand exchange reaction with [99Tc]EDTA.
    Garcia Muñoz M; Garcia Domenech R; Galvez Alvarez J; Moreno Frigols J
    Int J Appl Radiat Isot; 1983 Nov; 34(11):1505-8. PubMed ID: 6315599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physico-chemical study of the radiopharmaceuticals 99mTc-DMSA, 99mTc-EDTA and 99mTc-DTPA interaction with plasmatic proteins.
    Garcia Domenech R; Abril Mendez O; Galvez Alvarez J; Farga Marti A
    Int J Rad Appl Instrum A; 1989; 40(6):536-8. PubMed ID: 2551850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A convenient method for the preparation of 99mTc-labelled pentavalent DMSA and its evaluation as a tumour imaging agent.
    Babbar A; Kashyap R; Chauhan UP
    J Nucl Biol Med (1991); 1991; 35(2):100-4. PubMed ID: 1657203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxygen bubbling can improve the labelling of pentavalent technetium-99m dimercaptosuccinic acid.
    Kobayashi H; Suzuki KH; Sakahara H; Yao ZS; Yokoyama A; Konishi J
    Eur J Nucl Med; 1995 Jun; 22(6):559-62. PubMed ID: 7556304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Quantitation of absolute and relative renal uptake using 99mTc-DMSA: sequential change in time and correlation with 99mTc-DTPA uptake].
    Itoh K; Asano Y; Kato C; Nakada K; Nagao K; Goto T; Nonomura K; Furudate M
    Kaku Igaku; 1990 Mar; 27(3):237-42. PubMed ID: 2161961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Images of liposarcoma using technetium-99m bleomycin and technetium (V)-99m DMSA.
    Ohta H; Shane FI; Endo K; Torizuka K; Horiuchi K; Yokoyama A; Ishii M
    Clin Nucl Med; 1986 Dec; 11(12):842-4. PubMed ID: 2434276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Quantification of separate renal function using Tc 99m DTPA and Tc 99m DMSA. Correlations between individual isotopic data and creatinine clearance].
    Chevet D; Moisan A; Le Pogamp P; Le Cloirec J; Wehbe B; Herry JY
    Nephrologie; 1984; 5(1):21-5. PubMed ID: 6328339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A kinetic model for 99mTc-DMSA in the rat.
    Maneval DC; D'Argenio DZ; Wolf W
    Eur J Nucl Med; 1990; 16(1):29-34. PubMed ID: 2155115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the tumor-seeking agent Tc-99m(V) dimercaptosuccinic acid and the renal imaging agent Tc-99m dimercaptosuccinic acid in humans.
    Ohta H; Ishii M; Yoshizumi M; Endo K; Sakahara H; Nakajima T; Yomoda I; Masuda H; Horiuchi K; Hata N
    Clin Nucl Med; 1985 Mar; 10(3):167-70. PubMed ID: 2985320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and in vivo evaluation of 90Y-meso-dimercaptosuccinic acid (90Y-DMSA) for possible therapeutic use: comparison with 99mTc-DMSA.
    Djokić D; Janković D; Nikolić N
    Cancer Biother Radiopharm; 2009 Feb; 24(1):129-36. PubMed ID: 19243255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pentavalent technetium-99m (V)-DMSA uptake in a pheochromocytoma in a patient with Sipple's syndrome.
    Adams BK; Fataar A; Byrne MJ; Levitt NS; Matley PJ
    J Nucl Med; 1990 Jan; 31(1):106-8. PubMed ID: 1967305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and clinical evaluation of technetium-99m dimercaptosuccinic acid for tumour scintigraphy.
    Hirano T; Tomiyoshi K; Zhang YJ; Ishida T; Inoue T; Endo K
    Eur J Nucl Med; 1994 Jan; 21(1):82-5. PubMed ID: 8088289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low renal uptake of 99mTc-DMSA in patients with proximal tubular dysfunction.
    van Luÿk WH; Ensing GJ; Piers DA
    Eur J Nucl Med; 1983; 8(9):404-5. PubMed ID: 6313371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The chemical identity of pentavalent technetium-99m-dimercaptosuccinic acid.
    Blower PJ; Singh J; Clarke SE
    J Nucl Med; 1991 May; 32(5):845-9. PubMed ID: 1850782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraosseous hemangiomatosis: technetium-99m(V)dimercaptosuccinic acid and technetium-99m-hydroxymethylene diphosphonate imaging.
    Kobayashi H; Shigeno C; Sakahara H; Hosono M; Hosono M; Yao ZS; Endo K; Konishi J
    J Nucl Med; 1994 Sep; 35(9):1482-4. PubMed ID: 8071696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A convenient method for the preparation of 99mTc(V)dimercaptosuccinic acid (99mTc(V)-DMSA).
    Westera G; Gadze A; Horst W
    Int J Appl Radiat Isot; 1985 Apr; 36(4):311-2. PubMed ID: 2991143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technetium-99m-pentavalent dimercaptosuccinic acid uptake in Hurthle cell tumor of the thyroid.
    Vergara E; Lastoria S; Varrella P; Lapenta L; Salvatore M
    J Nucl Biol Med (1991); 1993 Jun; 37(2):65-8. PubMed ID: 8396979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comments on: "Two Routes for Renal 99mTc-DMSA Uptake into the Renal Cortical Tubular Cell".
    de Lange MJ; Kosterink JG; Piers DA; van Luijk WH; Meijer S
    Eur J Nucl Med; 1989; 15(9):633. PubMed ID: 2557216
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of chromatographic methods for quality control of DMSA complexes with 99mTc and 188Re at (III) and (V) oxidation states.
    Garnuszek P; Pawlak D; Maurin M; Jankovic D; Karczmarczyk U; Mikołajczak R
    Nucl Med Rev Cent East Eur; 2012 Aug; 15(2):95-100. PubMed ID: 22936501
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.